290 related articles for article (PubMed ID: 25419333)
1. [Intracystic papillary carcinoma of the breast: report of three cases].
El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
[TBL] [Abstract][Full Text] [Related]
2. Intracystic papillary carcinoma of the breast: differential diagnosis and management.
Mugler KC; Marshall C; Hardesty L; Finlayson C; Singh M
Oncology (Williston Park); 2007 Jun; 21(7):871-6. PubMed ID: 17722745
[No Abstract] [Full Text] [Related]
3. Intracystic papillary carcinoma: a rare clinical entity.
Kizilarslanoglu MC; Gezgen G; Roach EC; Altundag K
Am Surg; 2011 Dec; 77(12):E284. PubMed ID: 22273198
[No Abstract] [Full Text] [Related]
4. [ASCO/CAP guidelines and recommendations on hormonal receptor testing in breast cancer].
Wang T; Jiang ZF
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):721-2. PubMed ID: 21215158
[No Abstract] [Full Text] [Related]
5. [Zosteriform eruption resistant to acyclovir].
Orgaz-Molina J; Cotugno M; Aneiros-Fernández J; Arias-Santiago S
Med Clin (Barc); 2013 Aug; 141(4):188. PubMed ID: 23597955
[No Abstract] [Full Text] [Related]
6. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
7. Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma.
Ubillos N; Vola M; Mazzei ME; Magliano J
Actas Dermosifiliogr; 2016 Oct; 107(8):699-701. PubMed ID: 27206606
[No Abstract] [Full Text] [Related]
8. NCCN Guideline update: Breast Cancer Version 1.2004.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 May; 2(3):183-4. PubMed ID: 19795602
[No Abstract] [Full Text] [Related]
9. Déjà vu for breast cancer two?
Stearns V; Davidson NE
J Natl Cancer Inst; 2004 Apr; 96(7):497-9. PubMed ID: 15069104
[No Abstract] [Full Text] [Related]
10. [Therapeutic targeting in breast cancer].
Penault-Llorca F
Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
[No Abstract] [Full Text] [Related]
11. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up.
Wynveen CA; Nehhozina T; Akram M; Hassan M; Norton L; Van Zee KJ; Brogi E
Am J Surg Pathol; 2011 Jan; 35(1):1-14. PubMed ID: 21084964
[TBL] [Abstract][Full Text] [Related]
12. Primary neuroendocrine carcinoma of the breast A single Center experience and review of the literature.
Locurto P; Antona AD; Grillo A; Ciulla A; Martorana S; Cipolla C; Graceffa G; Vieni S
Ann Ital Chir; 2016 Nov; 87():. PubMed ID: 27905324
[TBL] [Abstract][Full Text] [Related]
13. "Acutely" enlarging breast: intracystic papillary carcinoma.
Dewey M; Schwabe M; Schneider A; Bick U
Rofo; 2011 Jul; 183(7):663-5. PubMed ID: 21305443
[No Abstract] [Full Text] [Related]
14. [Sebaceous breast carcinoma: report of a rare histological special subtype].
Wachter DL; Rauh C; Wenkel E; Fasching PA; Beckmann MW; Hartmann A
Pathologe; 2014 Feb; 35(1):72-6. PubMed ID: 24414613
[TBL] [Abstract][Full Text] [Related]
15. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
[TBL] [Abstract][Full Text] [Related]
16. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study.
Leal C; Costa I; Fonseca D; Lopes P; Bento MJ; Lopes C
Hum Pathol; 1998 Oct; 29(10):1097-104. PubMed ID: 9781648
[TBL] [Abstract][Full Text] [Related]
17. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
18. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
Ronay G; Sponsel N; Tulusan AH
Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
[No Abstract] [Full Text] [Related]
19. [Breast cancer adjuvants: results of a DUR (drug utilization research) study].
Nuzzo A
Suppl Tumori; 2004; 3(4):S86-7. PubMed ID: 15206223
[No Abstract] [Full Text] [Related]
20. The impact of systemic therapy following ductal carcinoma in situ.
Eng-Wong J; Costantino JP; Swain SM
J Natl Cancer Inst Monogr; 2010; 2010(41):200-3. PubMed ID: 20956830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
